Alnylam Pharmaceuticals, Inc.
$38.08B- Market cap
- $35.61B
- Debt
- +$4.12B
- Cash
- −$1.66B
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.82x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ALNY · current priceP/E 114.23x
$266.15Latest market snapshot
Implied fair value · at WLY's multiple
$27.0089.9% below market
2.33 ALNY EPS (TTM)×11.59x WLY P/E=$27.00
Market $266.15Implied $27.00
WLY · current priceP/E 11.59x
$48.20Latest market snapshot
Implied fair value · at ALNY's multiple
$475.19885.9% above market
4.16 WLY EPS (TTM)×114.23x ALNY P/E=$475.19
Market $48.20Implied $475.19